Lasa Supergenerics Ltd - 540702 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Omkar Pravin Herlekar Lasa Supergenerics Ltd - 540702 - Closure of Trading Window
This is to inform you that as per the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives w.e.f. April 01, 2023 till 48 hours after the declaration of audited financial results (both days inclusive) for the quarter & year ended March 31, 2023. Lasa Supergenerics Ltd - 540702 - Appointment of Company Secretary and Compliance Officer
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing obligation and disclosure Requirements) Regulations, 2015, we wish to inform you that we have appointed Mrs. Mitti Jain, Associate Member of ICSI as 'The Company Secretary and Compliance Officer' who will also be the Key Managerial Personnel of the Company w.e.f. March 21, 2023 pursuant to the provisions of the Section 203 of Companies Act, 2013 and Regulation 6(1) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. March 21, 2023
Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 12:00 Noon and concluded at 02:00 p.m. inter- alia has considered and approved the following:. On the recommendation of the Nomination and Remuneration committee the Board approved the Appointment of Mrs. Mitti Jain as Company Secretary & Compliance Officer of the company w.e.f March 21, 2023 as per the provisions of Section 203 of the Companies Act 2013 Mrs. Mitti Jain will be the Key Managerial Personnel of the Company. Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. February 14, 2023
we would like to inform you that the Board of Directors in their meeting held today which was commenced at 3.30 p.m. and concluded at 5.00 p.m. inter- alia have considered and approved the following: 1. The statement of unaudited Financial Results of the Company for the quarter ended on December 31, 2022. 2. Limited Review Report from Statutory Auditor for the quarter ended on December 31, 2022. Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
we wish to inform you that Ms. Ankita Shetty, Company Secretary and Compliance Officer of the Company have tendered her resignation w.e.f. 09th February 2023. Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Board Meeting Intimation
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, February 14, 2023 to consider, approve and take on record Un-audited financial results along with limited review report for the quarter ended December 31, 2022 and / or to discuss and any other business / matter with the permission of chair Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2022 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company. Lasa Supergenerics Ltd - 540702 - Closure of Trading Window
This is to inform you that as per the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives w.e.f. January 01, 2023 till 48 hours after the declaration of unaudited financial results (both days inclusive) for the quarter ended December 31, 2022. Lasa Supergenerics Ltd - 540702 - Disclosure Under Reg 30 Of SEBI (Listing Obligations And Disclosure Requirements ) Regulations ,2015 Regarding Approval Of Scheme Of Amalgamation By Thehon'Ble NCLT
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, we wish to Inform you that The Scheme of Amalgamation of Harishree Aromatics and Chemicals Private Limited, the Transferor Company with Lasa Supergenerics Limited, the Transferee Company is approved by Hon'ble National Company Law Tribunal, Mumbai Bench on Friday, December 23, 2022